Science Explorer Back to mapMap
Discussion
Researcher · Anthem Biosciences (India) · India

Nandini Pal Basak

Nandini Pal Basak publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and CAR-T cell therapy research.

ORCID 0000-0003-4291-6159 OpenAlex
World rank
#2,489,584
of 7,710,434 ranked researchers
Rank in India
#46,929
of 280,097
Works
85
Citations
302
Citations per work
3.6
h-index
7
i10-index 6Top 78% in Oncology
Nandini Pal Basak

What does Nandini Pal Basak research?

Nandini Pal Basak's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (14%).

Health Sciences: 43 works · 50.1% of their workMedicine: 43 works · 50.1% of their workOncology: 33 works · 38.8% of their workPulmonary and Respiratory Medicine: 7 works · 8.2% of their workHematology: 3 works · 3.1% of their workLife Sciences: 31 works · 36.8% of their workBiochemistry, Genetics and Molecular Biology: 19 works · 22.5% of their workMolecular Biology: 12 works · 14.3% of their workCancer Research: 7 works · 8.2% of their workImmunology and Microbiology: 12 works · 14.3% of their workImmunology: 12 works · 14.3% of their workEverything else: 11 works · 13.1% of their workTHEIR WORKNandini Pal Basak85works
Life Sciences37%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4350.1%
    1. Biochemistry, Genetics and Molecular Biology1922.5%
    2. Immunology and Microbiology1214.3%
  3. Everything else1113.1%
  1. 1Oncology39% of their works
  2. 2Immunology14% of their works
  3. 3Molecular Biology14% of their works
  4. 4Cancer Research8% of their works
  5. 5Pulmonary and Respiratory Medicine8% of their works
  6. 6Hematology3% of their works

Research topics

Which keywords describe Nandini Pal Basak's research?

The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Cancer Immunotherapy, Immunity, Targeted Therapy, Antigen Presentation, CAR T Cells and Chimeric Antigen Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Immune Checkpoint Blockade181 topic
  2. PD-1 and PD-L1181 topic
  3. Cancer Immunotherapy142 topics
  4. Immunity112 topics
  5. Targeted Therapy92 topics
  6. Antigen Presentation71 topic
  7. CAR T Cells71 topic
  8. Chimeric Antigen Receptor71 topic
  9. Dendritic Cells71 topic
  10. Cancer Genomics61 topic
  11. Mutational Signatures61 topic
  12. Activation41 topic
  13. Macrophage41 topic
  14. ALK Inhibitors31 topic
  15. Cancer Stem Cells31 topic
  16. DNA Methylation31 topic
  17. EGFR Mutations31 topic
  18. Histone Modification31 topic
  19. Tumor Metastasis31 topic

Where does Nandini Pal Basak work?

Nandini Pal Basak's main affiliation in the publication record is Anthem Biosciences (India), India.

How many publications and citations does Nandini Pal Basak have?

OpenAlex counts 85 works and 302 citations for Nandini Pal Basak, an h-index of 7, ranking #2,489,584 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nandini Pal Basak. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.